POLYCYTHEMIA VERA

Course overview

POLYCYTHEMIA VERA IS A MYELOPROLIFERATIVE DISORDER ASSOCIATED WITH A JANUS KINASE-2 (JAK2) MUTATION THAT CAUSES THE NEOPLASTIC PROLIFERATION OF THE HEMATOPOIETIC PROGENITOR CELLS. IT CAUSES ELEVATED RED BLOOD CELL PRODUCTION ALONG WITH SECONDARY WHITE BLOOD CELL AND PLATELET PRODUCTION. DISEASE COMPLICATIONS ARE ASSOCIATED WITH INCREASED BLOOD VISCOSITY, INCLUDING THROMBOSES. THIS ACTIVITY REVIEWS THE EVALUATION AND TREATMENT OF POLYCYTHEMIA VERA AND HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN IMPROVING CARE FOR PATIENTS WITH THIS CONDITION.